Literature DB >> 21044961

MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).

Soken Tsuchiya1, Takeshi Fujiwara, Fumiaki Sato, Yutaka Shimada, Eiji Tanaka, Yoshiharu Sakai, Kazuharu Shimizu, Gozoh Tsujimoto.   

Abstract

The importance of microRNAs (miRNAs) in human malignancies has been well recognized. Here, we report that the expression of microRNA-210 (miR-210) is down-regulated in human esophageal squamous cell carcinoma and derived cell lines. Marked decreases in the level of miR-210 were observed especially in poorly differentiated carcinomas. We found that miR-210 inhibits cancer cell survival and proliferation by inducing cell death and cell cycle arrest in G(1)/G(0) and G(2)/M. Finally, we identified fibroblast growth factor receptor-like 1 (FGFRL1) as a target of miR-210 in esophageal squamous cell carcinoma and demonstrated that FGFRL1 accelerates cancer cell proliferation by preventing cell cycle arrest in G(1)/G(0). Taken together, our findings show an important role for miR-210 as a tumor-suppressive microRNA with effects on cancer cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044961      PMCID: PMC3013001          DOI: 10.1074/jbc.M110.170852

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  microRNA target predictions in animals.

Authors:  Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

Review 2.  MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer.

Authors:  Soken Tsuchiya; Yasushi Okuno; Gozoh Tsujimoto
Journal:  J Pharmacol Sci       Date:  2006-08       Impact factor: 3.337

3.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

4.  A microRNA signature of hypoxia.

Authors:  Ritu Kulshreshtha; Manuela Ferracin; Sylwia E Wojcik; Ramiro Garzon; Hansjuerg Alder; Francisco J Agosto-Perez; Ramana Davuluri; Chang-Gong Liu; Carlo M Croce; Massimo Negrini; George A Calin; Mircea Ivan
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

5.  The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.

Authors:  Eiji Tanaka; Yosuke Hashimoto; Tetsuo Ito; Kan Kondo; Motoshige Higashiyama; Shigeru Tsunoda; Cristian Ortiz; Yoshiharu Sakai; Johji Inazawa; Yutaka Shimada
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

6.  Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Tetsuo Ito; Yutaka Shimada; Takatsugu Kan; Stefan David; Yulan Cheng; Yuriko Mori; Rachana Agarwal; Bogdan Paun; Zhe Jin; Alexandru Olaru; James P Hamilton; Jian Yang; John M Abraham; Stephen J Meltzer; Fumiaki Sato
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 7.  Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity.

Authors:  Jiri Zavadil; Manisha Narasimhan; Miroslav Blumenberg; Robert J Schneider
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

8.  hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Authors:  Carme Camps; Francesca M Buffa; Stefano Colella; John Moore; Christos Sotiriou; Helen Sheldon; Adrian L Harris; Jonathan M Gleadle; Jiannis Ragoussis
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

9.  miRBase: microRNA sequences, targets and gene nomenclature.

Authors:  Sam Griffiths-Jones; Russell J Grocock; Stijn van Dongen; Alex Bateman; Anton J Enright
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  88 in total

1.  A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts.

Authors:  R Faraonio; P Salerno; F Passaro; C Sedia; A Iaccio; R Bellelli; T C Nappi; M Comegna; S Romano; G Salvatore; M Santoro; F Cimino
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

2.  Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.

Authors:  Eun-Jung Jung; Libero Santarpia; Juyeon Kim; Francisco J Esteva; Erica Moretti; Aman U Buzdar; Angelo Di Leo; Xiao-Feng Le; Robert C Bast; Soon-Tae Park; Lajos Pusztai; George A Calin
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

3.  The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.

Authors:  Isabelle Bar; Ahmad Merhi; Fadi Abdel-Sater; Abduelhakem Ben Addi; Sara Sollennita; Jean-Luc Canon; Paul Delrée
Journal:  J Histochem Cytochem       Date:  2017-04-12       Impact factor: 2.479

4.  Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

Authors:  Yi Zhou; Liu Hong
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-13

5.  Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.

Authors:  H Cui; B Seubert; E Stahl; H Dietz; U Reuning; L Moreno-Leon; M Ilie; P Hofman; H Nagase; B Mari; A Krüger
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

6.  Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.

Authors:  Yunfeng Yi; Jianming Chen; Changjie Jiao; Jing Zhong; Zhiming Song; Xiaoping Yu; Xiujuan Lu; Baoli Lin
Journal:  Oncol Lett       Date:  2016-10-05       Impact factor: 2.967

7.  MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.

Authors:  Xiaoming Yang; Lei Shi; Chengzhi Yi; Yang Yang; Liansheng Chang; Dongkui Song
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.

Authors:  Xin Chen; Jia Guo; Ru-Xing Xi; Yu-Wei Chang; Fei-Yang Pan; Xiao-Zhi Zhang
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Senescent stroma promotes prostate cancer progression: the role of miR-210.

Authors:  Maria Letizia Taddei; Lorenzo Cavallini; Giuseppina Comito; Elisa Giannoni; Marco Folini; Alberto Marini; Paolo Gandellini; Andrea Morandi; Gianfranco Pintus; Maria Rosaria Raspollini; Nadia Zaffaroni; Paola Chiarugi
Journal:  Mol Oncol       Date:  2014-07-21       Impact factor: 6.603

Review 10.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.